Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Zen Rating
Growth
Market Cap
Revenue
EBITDA
Earnings
EPS
Rev. Y/Y
Rev. 5Y
Earn. Y/Y
Earn. 5Y
Earnings Date
FBLG
FIBROBIOLOGICS INC
$22.87M$0.00-$12.55M-$13.22M-$0.36N/AN/AN/AN/A2025-11-18
ACXP
ACURX PHARMACEUTICALS INC
$6.80M$0.00-$10.00M-$10.00M-$10.69N/AN/AN/AN/A2025-11-18
IOBT
IO BIOTECH INC
$23.91M$0.00-$101.93M-$103.99M-$1.58N/AN/AN/AN/A2025-11-05
KALA
KALA BIO INC
$9.87M$0.00-$29.63M-$35.65M-$7.97N/A-100.00%N/AN/A
FEMY
FEMASYS INC
$9.59M$1.70M-$18.54M-$21.11M-$0.9161.97%N/AN/AN/A2025-11-06
ATYR
ATYR PHARMA INC
$64.17M$0.00-$62.26M-$63.41M-$0.80-100.00%-100.00%N/AN/A
MRSN
MERSANA THERAPEUTICS INC
$38.73M$34.77M-$65.59M-$74.04M-$14.6216.14%83.02%N/AN/A2025-11-11
GOVX
GEOVAX LABS INC
$12.00M$0.00-$24.71M-$24.81M-$2.01N/A-100.00%N/AN/A
UNCY
UNICYCIVE THERAPEUTICS INC
$77.01M$0.00-$30.97M-$31.56M-$3.62N/AN/AN/AN/A
RANI
RANI THERAPEUTICS HOLDINGS INC
$28.77M$1.20M-$22.18M-$29.80M-$0.99N/AN/AN/AN/A2025-11-12
SGMO
SANGAMO THERAPEUTICS INC
$203.05M$81.71M-$55.42M-$64.59M-$0.29565.52%-6.02%N/AN/A2025-10-30
FGEN
FIBROGEN INC
$49.54M-$72.84M$2.18M-$2.07M-$0.38N/AN/AN/AN/A
PSTV
PLUS THERAPEUTICS INC
$67.50M$5.32M-$14.57M-$19.03M-$2.03-3.49%-3.22%N/AN/A
GRI
GRI BIO INC
$5.18M$0.00-$10.02M-$11.92M$3.81N/AN/A-99.72%N/A
NRXP
NRX PHARMACEUTICALS INC
$65.03M$0.00-$33.79M-$33.79M-$2.24N/AN/AN/AN/A
BTAI
BIOXCEL THERAPEUTICS INC
$37.27M$868.00k-$34.61M-$50.95M-$11.94-63.88%N/AN/AN/A
MDCX
MEDICUS PHARMA LTD
$41.24M$0.00-$16.73M-$16.51M-$1.34N/AN/AN/AN/A2025-11-21
PMN
PROMIS NEUROSCIENCES INC
$22.28M$0.00-$8.43M-$8.43M-$0.21N/AN/AN/AN/A2025-11-12
OSTX
OS THERAPIES INC
$62.51M$0.00-$13.72M-$16.25M-$0.79N/AN/AN/AN/A
ENLV
ENLIVEX THERAPEUTICS LTD
$24.81M$0.00-$14.99M-$13.10M-$0.58N/AN/AN/AN/A2025-12-01
MTVA
METAVIA INC
$22.75M$0.00-$18.47M-$18.49M-$1.49N/AN/AN/AN/A
BOLT
BOLT BIOTHERAPEUTICS INC
$10.21M$4.17M-$47.13M-$50.71M-$26.46-62.68%N/AN/AN/A
CING
CINGULATE INC
$21.22M$0.00-$17.32M-$17.96M-$4.10N/AN/AN/AN/A
INTS
INTENSITY THERAPEUTICS INC
$11.44M$0.00-$12.55M-$12.58M-$0.82N/AN/AN/AN/A2025-11-18
KAPA
KAIROS PHARMA LTD
$24.27M$0.00-$4.70M-$4.71M-$0.34N/AN/AN/AN/A
LSTA
LISATA THERAPEUTICS INC
$22.53M$1.00M-$20.10M-$19.31M-$2.30N/AN/AN/AN/A2025-11-06
CERO
CERO THERAPEUTICS HOLDINGS INC
$6.14M$0.00-$12.97M-$41.91M-$66.53N/AN/AN/AN/A
MYO
MYOMO INC
$33.72M$40.76M-$7.41M-$9.32M-$0.2293.07%59.13%N/AN/A2025-11-05
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$25.09M$0.00-$27.07M-$27.11M-$0.65N/AN/AN/AN/A2025-11-17
JSPR
JASPER THERAPEUTICS INC
$38.68M$0.00-$88.84M-$90.92M-$6.03N/AN/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$88.46M$0.00-$27.19M-$27.41M-$0.34N/AN/AN/AN/A2025-11-18
SLN
SILENCE THERAPEUTICS PLC
$244.90M$27.37M-$73.76M-$79.40MN/A21.64%73.57%N/AN/A2025-11-13
NOTE
FISCALNOTE HOLDINGS INC
$66.44M$109.68M-$24.45M-$45.84M-$3.84-15.39%N/AN/AN/A2025-11-18
IPSC
CENTURY THERAPEUTICS INC
$43.02M$114.13M-$7.37M-$23.28M-$0.295,489.03%N/AN/AN/A2025-11-06
IMUX
IMMUNIC INC
$84.51M$0.00-$96.19M-$96.40M-$0.95N/AN/AN/AN/A2025-11-06
MBRX
MOLECULIN BIOTECH INC
$16.05M$0.00-$26.43M-$26.55M-$3.52N/AN/AN/AN/A
PASG
PASSAGE BIO INC
$25.53M$0.00-$55.01M-$56.86M-$18.16N/AN/AN/AN/A2025-11-18
TIL
INSTIL BIO INC
$120.57M$0.00-$74.48M-$84.51M-$12.92N/AN/AN/AN/A
SNSE
SENSEI BIOTHERAPEUTICS INC
$11.92M$0.00-$24.46M-$26.82M-$21.31N/AN/AN/AN/A
ACET
ADICET BIO INC
$66.99M$0.00-$107.56M-$117.32M-$1.29N/AN/AN/AN/A2025-11-05
ATOS
ATOSSA THERAPEUTICS INC
$111.99M$0.00-$28.70M-$28.72M-$0.23N/AN/AN/AN/A2025-11-17
EKSO
EKSO BIONICS HOLDINGS INC
$13.40M$14.65M-$9.25M-$11.09M-$6.64-19.32%6.35%N/AN/A
ANVS
ANNOVIS BIO INC
$40.34M$0.00-$30.26M-$30.26M-$1.99N/AN/AN/AN/A2025-11-05
ALLO
ALLOGENE THERAPEUTICS INC
$275.13M$0.00-$223.22M-$236.91M-$1.11-100.00%N/AN/AN/A2025-10-30
SNTI
SENTI BIOSCIENCES INC
$36.77M$0.00-$49.48M-$54.79M-$10.79-100.00%N/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.